Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
about
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challengeWhole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.Maternal immunity partially protects newborn mice against a Chlamydia trachomatis intranasal challengeInduction of immune memory by a multisubunit chlamydial vaccineImmunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathologyIntranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice.Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccineImmunization with dendritic cells pulsed ex vivo with recombinant chlamydial protease-like activity factor induces protective immunity against genital chlamydiamuridarum challengeInduction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxinProtection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.B cells are essential for moderating the inflammatory response and controlling bacterial multiplication in a mouse model of vaccination against Chlamydophila abortus infectionTowards a Chlamydia trachomatis vaccine: how close are we?Update on Chlamydia trachomatis Vaccinology.
P2860
Q28391567-1EE561F8-15E3-4B78-8BCD-559C26DFF2D8Q33957971-14C05101-AAED-4F17-80C7-71C62B14C6E3Q34172833-7ECC96B3-8BB9-4565-8FB0-E27C1B1BBAD1Q34546923-E48FAAF6-8FD8-4D0B-8BEA-115EF363254EQ34685461-7AAF5BD7-FB15-4D6D-9701-2F84003BEAC3Q34760989-93AF6912-222B-4321-84E1-B5006308E6DCQ35042764-027C6534-E3BF-4ED2-8BD4-CD3746A44F73Q35927600-FEC2253D-718C-4485-913F-7C9E6BD6A6E8Q36593534-92B81D4D-8E47-4406-BA13-C99895A96D16Q37341897-3BC2E746-2684-47C9-BA4F-86199BA781F2Q37410328-8FF750D6-38D3-4B4C-97CA-1DB11BBAE2CCQ37820669-8AA700CC-9573-453E-AA52-65043F5ED720Q37834874-49063D2B-E81F-43D2-A836-F71FCFBE21EA
P2860
Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Protection of wild-type and se ...... major outer membrane protein.
@en
type
label
Protection of wild-type and se ...... major outer membrane protein.
@en
prefLabel
Protection of wild-type and se ...... major outer membrane protein.
@en
P2093
P2860
P356
P1476
Protection of wild-type and se ...... major outer membrane protein.
@en
P2093
Ellena M Peterson
Jose Bravo
Luis M de la Maza
Sukumar Pal
P2860
P304
P356
10.1128/IAI.00574-08
P407
P577
2008-09-22T00:00:00Z